Clinical predictors of benefit from fulvestrant in advanced breast cancer: A meta-analysis of randomized controlled trials

被引：0
|
作者：
Niraula, S.
Pitz, M.
Gordon, V.
Grenier, D.
Amir, E.
Brandes, L.
机构：
[1] CancerCare Manitoba, Winnipeg, MB, Canada
[2] Univ Manitoba, Winnipeg, MB, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON M5S 1A1, Canada
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-14-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-14-02
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical predictors of benefit from fulvestrant in advanced breast cancer: A Meta-analysis of randomized controlled trials
    Graham, Jeffrey
    Pitz, Marshall
    Gordon, Vallerie
    Grenier, Debjani
    Amir, Eitan
    Niraula, Saroj
    CANCER TREATMENT REVIEWS, 2016, 45 : 1 - 6
  • [2] Fulvestrant in the treatment of advanced breast cancer: A systematic review and meta-analysis of randomized controlled trials
    Valachis, Antonis
    Mauri, Davide
    Polyzos, Nikolaos P.
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Casazza, Giovanni
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 73 (03) : 220 - 227
  • [3] Fulvestrant in the treatment of advanced breast cancer: A systematic review and meta-analysis of randomized controlled trials
    Mauri, D.
    Valachis, A.
    Polyzos, N. P.
    Mavroudis, D.
    Georgoulias, V.
    Casazza, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Fulvestrant for advanced breast cancer: A meta-analysis
    Al-Mubarak, Mustafa
    Sacher, Adrian G.
    Ocana, Alberto
    Vera-Badillo, Francisco
    Seruga, Bostjan
    Amir, Eitan
    CANCER TREATMENT REVIEWS, 2013, 39 (07) : 753 - 758
  • [5] Fulvestrant 250mg versus Anastrozole 1 mg in the Treatment of Advanced Breast Cancer: a Meta-Analysis of Randomized Controlled Trials
    Gong, Dan-Dan
    Man, Chang-Feng
    Xu, Juan
    Fan, Yu
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (05) : 2095 - 2100
  • [6] Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials
    Meng Li
    Yiting Xiong
    Chen Liao
    Yunyan He
    Sijia Duan
    Fengming Yi
    Yiping Wei
    Wenxiong Zhang
    Breast Cancer Research and Treatment, 2020, 180 : 269 - 278
  • [7] Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials
    Li, Meng
    Xiong, Yiting
    Liao, Chen
    He, Yunyan
    Duan, Sijia
    Yi, Fengming
    Wei, Yiping
    Zhang, Wenxiong
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 269 - 278
  • [8] Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials
    Fausto Petrelli
    Sandro Barni
    Giacomo Bregni
    Filippo de Braud
    Serena Di Cosimo
    Breast Cancer Research and Treatment, 2016, 160 : 425 - 437
  • [9] Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials
    Petrelli, Fausto
    Barni, Sandro
    Bregni, Giacomo
    de Braud, Filippo
    Di Cosimo, Serena
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (03) : 425 - 437
  • [10] Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials
    Mocellin, Simone
    Pilati, Pierluigi
    Briarava, Marta
    Nitti, Donato
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02):
12345